THRYVE HAIR LAB’S LATEST NEWS

Androgenetic alopecia affects millions of men, but modern hair loss and baldness treatment options can slow, stop, and even reverse thinning. This 2026 guide breaks down the causes, FDA-approved therapies, and why a combined dutasteride-minoxidil approach may outperform traditional single-ingredient regimens.

Curious what a natural DHT blocker actually is and how it works? This guide breaks down the biology of DHT, explains the two distinct mechanisms natural compounds use to interfere with it, and shows how they measure up against prescription options like finasteride.

Searching for hair growth medicine for female options can feel overwhelming with so many conflicting claims. This article cuts through the noise, revealing the only two FDA-approved treatments for female pattern hair loss and explaining why popular male-focused drugs like finasteride don't apply to women.

Confused by conflicting studies on dutasteride vs finasteride sexual side effects? This article breaks down the real clinical numbers, reconciles contradictory research, and covers the latest 2025 EMA ruling for a clear, honest comparison.

Derma roller hair regrowth claims are everywhere, but the clinical evidence tells a more nuanced story. This 2026 guide breaks down why dermarolling works best as an adjunct—not a replacement—for minoxidil and DHT blockers, with the exact needle size and frequency protocols men need for real results.

Understanding your male hair baldness pattern is the first step toward effective treatment. This 2026 guide breaks down every stage of the Hamilton–Norwood scale, including often-overlooked Type A variants, and reveals why timing your response matters more than the number itself.